1st Oct 2021 10:44
SkinBioTherapeutics PLC - Manchester-based life science company focused on skin health - Prepares for a "soft launch" in the UK and US of its probiotic food supplement for psoriasis, named AxisBiotix-Ps. Says commercialisation will begin on October 29, which is World Psoriasis Day. Pushes ahead with final regulation and commercial stages after the product received a positive consumer study in May. Through its subsidiary AxisBiotix Ltd, the company receives and stores the finished product at its distribution centre in the Netherlands. Says sales will initially be restricted to a limited number of customers to ensure it has a "robust and reliable supply chain". After this, the company says it will sell AxisBiotix-Ps online to the remainder of any waiting list for the product and the wider psoriatic population.
Current stock price: 69.55 pence, up 0.8% on Friday morning
Year-to-date change: up from 23.50p on December 31
By Scarlett Butler; [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
Skinbiotherap.